A novel case of acute localized and generalized exanthematous pustulosis following IL-2 analogue injection amplified by immune checkpoint inhibition

By afschroeder • December 10, 2025

Johnsen NA, Carlisle R, Baghoomian W, Pierce JL, Nguyen MO. A novel case of acute localized and generalized exanthematous pustulosis following IL-2 analogue injection amplified by immune checkpoint inhibition. JAAD Case Rep. 2025 Oct 27;67:36-39. doi: 10.1016/j.jdcr.2025.10.025. PMID: 41362852; PMCID: PMC12681758.

Tags: acute generalized exanthematous pustulosis, acute localized exanthematous pustulosis, cutaneous immune-related adverse event, Dermatology, Drug reaction, drug-induced exanthem, immune checkpoint inhibitor, injection site reaction, pembrolizumab, Publications, pustules, Resident

Association between out-of-pocket costs and treatment patterns in psoriasis and psoriatic arthritis: A claims-based cohort study

Roberts AM, Jeong C, Chou P, Ma EJ, Katz A, Yan MJ, Johnsen N, Nong Y, Armstrong AW. Association between out-of-pocket costs and treatment patterns[...]

Central centrifugal cicatricial alopecia is associated with longer time to diagnosis among scarring alopecias

Issa T, Klomhaus AM, Kasakevich C, Pickford J, Goh C. Central centrifugal cicatricial alopecia is associated with longer time to diagnosis among scarring alopecias. JAAD[...]

Quantifying Treatment Burden in Hidradenitis Suppurativa: A Cohort Study

Jeong C, Roberts A, Hur M, Chou P, Katz A, Ma E, Yan MJ, Johnsen N, Nong Y, Armstrong AW. Quantifying Treatment Burden in Hidradenitis[...]